US clinical-stage biotech Halda Therapeutics today announced that Dr Eyal Attar has joined the company as chief medical ...

A clinical-stage biotech company developing bifunctional small-molecule therapeutics designed to eliminate disease-driving ...

Harvard University has filed a lawsuit against the US government after more than $2 billion in federal research funding was ...

A biotech company integrating of AI and synthetic biology to design safer and more effective antibody therapeutics.

A clinical-stage biotech company developing first-in-class targeted and immune-mediated therapeutics to fight cancer.

Galapagos (Euronext: GLPG) has appointed Henry Gosebruch as chief executive of its upcoming oncology spin-off, marking a ...

Physician attitudes toward patient choice between the use of biologics and biosimilars vary widely across global markets, ...

Japan’s Ono Pharmaceutical and privately-held US firm Jorna Therapeutics are ready to go in a research collaboration ...

Zymeworks (Nasdaq: ZYME), a clinical-stage biotech developing antibody-based therapies for cancer and immune diseases, has ...

US biotech major Gilead Sciences (Nasdaq: GILD) today announced positive top-line results from the Phase III ...

Russian public procurements of drugs based on the active ingredient semaglutide, which is an original drug from Denmark’s ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi (marstacimab) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35kg with ...